FUNDAMENTALS · Fundamentals · US Healthcare

MiniMed Group, Inc. Common Stock (MMED) Fundamentals 2026 — Revenue Analysis | SniperIQ

MiniMed Group, Inc. Common Stock (MMED) is a US-listed Healthcare company in Medical - Equipment & Services with a market capitalization of $4.6B, trading at

6.34 on the NASDAQ. This SniperIQ fundamentals page covers MiniMed Group, Inc. Common Stock's valuation, profitability (net margin -21.7%), revenue (
.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$4.6B
Net Margin-21.7%
Revenue (FY25)
.1B

Full research coverage

Frequently Asked Questions

What is MiniMed Group, Inc. Common Stock's market cap?

MiniMed Group, Inc. Common Stock (MMED) has a market capitalization of approximately $4.6B, trading at

6.34 on the NASDAQ. Market cap moves with the live share price.

What is MiniMed Group, Inc. Common Stock's P/E ratio?

MiniMed Group, Inc. Common Stock's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is MiniMed Group, Inc. Common Stock?

MiniMed Group, Inc. Common Stock runs a net profit margin of -21.7%, a gross margin of 52.9%, and an operating margin of -9.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does MiniMed Group, Inc. Common Stock generate?

MiniMed Group, Inc. Common Stock reported revenue of

.1B for fiscal year 2025, with net income of -
31M and earnings per share (EPS) of -1.29. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does MiniMed Group, Inc. Common Stock pay a dividend?

MiniMed Group, Inc. Common Stock does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is MiniMed Group, Inc. Common Stock financially healthy?

MiniMed Group, Inc. Common Stock carries a debt-to-equity ratio of 0.04x and a current ratio of 1.92x, with a market beta of -3.63. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is MiniMed Group, Inc. Common Stock a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For MiniMed Group, Inc. Common Stock (MMED) the key facts are: market cap $4.6B, revenue

.1B, 52-week range 10.65-20.48. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track MiniMed Group, Inc. Common Stock's full fundamentals live

Get MiniMed Group, Inc. Common Stock's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.